SCNI · Scinai Immunotherapeutics Ltd. · Documents
Market Cap
$921,954
Shares
1.35M
Volume · Oct 21
181.3K
Avg daily vol (43 sessions)
3.17M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2021-10-25 | 2021-10-24 | |
| 6-K | — | 2021-08-26 | — | |
| 6-K | — | 2021-06-23 | — | |
| 6-K | — | 2021-05-13 | — | |
| 20-F | — | 2021-05-13 | 2020-12-31 | |
| NT 20-F | — | 2021-04-29 | 2020-12-31 | |
| 6-K | — | 2021-04-06 | — | |
| 6-K | — | 2021-03-23 | — | |
| 6-K | — | 2021-03-22 | — | |
| 6-K | — | 2021-03-16 | — | |
| 6-K | — | 2021-03-04 | — | |
| 6-K | — | 2021-02-24 | — | |
| 6-K | — | 2021-02-17 | — | |
| 6-K | — | 2021-02-11 | 2021-02-10 | |
| 6-K | — | 2021-02-08 | — | |
| 6-K | — | 2021-02-02 | 2021-02-01 | |
| 6-K | — | 2021-02-02 | — | |
| 6-K | — | 2021-01-29 | — | |
| 6-K | — | 2021-01-29 | 2021-01-28 | |
| 6-K | — | 2021-01-28 | 2020-09-30 | |
| 6-K | — | 2021-01-21 | — | |
| 6-K | — | 2020-10-23 | — | |
| 6-K | — | 2020-10-02 | 2020-06-30 | |
| 6-K | — | 2020-10-02 | 2020-10-01 | |
| 6-K | — | 2020-09-02 | — | |
| 6-K | — | 2020-09-01 | — | |
| 6-K | — | 2020-08-24 | 2020-08-23 | |
| 6-K | — | 2020-08-17 | — | |
| 6-K | — | 2020-08-05 | — | |
| F-3 | — | 2020-07-29 | — | |
| 6-K | — | 2020-07-28 | — | |
| 6-K | — | 2020-07-01 | — | |
| 6-K | — | 2020-07-01 | — | |
| 6-K | — | 2020-06-12 | — | |
| 20-F | — | 2020-06-12 | 2019-12-31 | |
| 6-K | — | 2020-06-10 | — | |
| 6-K | — | 2020-05-20 | — | |
| 6-K | — | 2020-05-04 | — | |
| 6-K | — | 2020-04-30 | — | |
| 6-K | — | 2020-03-24 | — | |
| 6-K | — | 2020-03-19 | — | |
| 6-K | — | 2020-02-25 | — | |
| 6-K/A | — | 2020-02-10 | — | |
| 6-K | — | 2020-02-10 | — | |
| 6-K | — | 2020-02-05 | — | |
| 6-K | — | 2020-01-16 | — | |
| 6-K | — | 2020-01-16 | — | |
| 6-K | — | 2020-01-13 | — |
Showing 151–198 of 198 filings